IL-17/IL-17RA subsequently activated NF-κB pathway and STAT3 pathway, triggering the transcription of various downstream target genes, including PD-L1, Cyclin family members, MMPs, and EMT makers (Fig. 8), which may lead to immune evasion, tumor growth, and tumor invasion of PCa. The gene discussed is IL17A; the disease is neoplasm.